Mini Gastric Bypass vs Roux enY Gastric Bypass (MGB vs RYGB)
調査の概要
詳細な説明
The main aim of this project is to develop an ideal bariatric/metabolic surgery operation.
The ideal features are highly safe operation, revisable, reversible, extremely effective, short operative time, short hospital stay, cost-effective, no long-term complications and acceptable to the patients.
Mini Gastric Bypass/One Anastomosis Gastric Bypass MGB/OAGB is relatively a new bariatric /metabolic surgery operation that is increasing in popularity and currently more than 60,000 operations are performed worldwide. Only 125 MGB operations are published from UK.
No previous RCT to date in the UK to test the new operation although RCT was done in Taiwan 2005 and showed that MGB is not inferior to the Roux EnY Gastric Bypass RYGB. This research project is assessing the outcomes of this operation and opening the doors to understand its effects and how it works compared to the standard RYGB. The possible development in the project is to study the hormonal changes after the MGB.
研究の種類
段階
- 適用できない
連絡先と場所
研究場所
-
-
South Yorkshire
-
Doncaster、South Yorkshire、イギリス、DN2 5LT
- Doncaster & Bassetlaw Teaching Hospitals NHS Foundation Trust
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- They have a BMI of 40 kg/m2 or more, or between 35 kg/m2 and 40 kg/m2 and other significant disease (for example, type 2 diabetes or high blood pressure) that could be improved if they lost weight.
- All appropriate non-surgical measures have been tried but the person has not achieved or maintained adequate, clinically beneficial weight loss.
- The person has been receiving or will receive intensive management in a tier 3 service.
- The person is generally fit for anaesthesia and surgery.
- The person commits to the need for long-term follow-up
Exclusion Criteria:
- Not meeting the eligibility criteria
- Under 18s
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
アクティブコンパレータ:MGB
Mini gastric bypass
|
Surgical method of gastric bypass
|
アクティブコンパレータ:Roux enY gastric bypass
|
Surgical method of gastric bypass
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Excess weight loss
時間枠:2 years post surgery
|
Amount of weight lost
|
2 years post surgery
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Type 2 diabetes remission
時間枠:6 months, 2 years, 5 years and 10 years
|
Type 2 diabetes remission
|
6 months, 2 years, 5 years and 10 years
|
Morbidity
時間枠:6 months, 2 years, 5 years and 10 years
|
Morbidity
|
6 months, 2 years, 5 years and 10 years
|
Mortality
時間枠:6 months, 2 years, 5 years and 10 years
|
Mortality
|
6 months, 2 years, 5 years and 10 years
|
Operative time
時間枠:6 months, 2 years, 5 years and 10 years
|
Operative time
|
6 months, 2 years, 5 years and 10 years
|
Length of stay
時間枠:6 months, 2 years, 5 years and 10 years
|
Length of stay
|
6 months, 2 years, 5 years and 10 years
|
Readmission rate
時間枠:6 months, 2 years, 5 years and 10 years
|
Readmission rate
|
6 months, 2 years, 5 years and 10 years
|
Lipid profile
時間枠:6 months, 2 years, 5 years and 10 years
|
Lipid profile
|
6 months, 2 years, 5 years and 10 years
|
Malnutrition
時間枠:6 months, 2 years, 5 years and 10 years
|
Malnutrition
|
6 months, 2 years, 5 years and 10 years
|
Liver failure
時間枠:6 months, 2 years, 5 years and 10 years
|
Liver failure
|
6 months, 2 years, 5 years and 10 years
|
Gastro-oesophageal reflux
時間枠:6 months, 2 years, 5 years and 10 years
|
Gastro-oesophageal reflux
|
6 months, 2 years, 5 years and 10 years
|
Upper GI cancer
時間枠:6 months, 2 years, 5 years and 10 years
|
Upper GI cancer
|
6 months, 2 years, 5 years and 10 years
|
Diarrhoea
時間枠:6 months, 2 years, 5 years and 10 years
|
Diarrhoea
|
6 months, 2 years, 5 years and 10 years
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (予想される)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 0945 2018 NCTS
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Gastric bypassの臨床試験
-
Polyak, MaximilianHealth Resources and Services Administration (HRSA)完了
-
Joslin Diabetes CenterBrigham and Women's Hospital完了